What is the treatment for bursitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Bursitis

The treatment of bursitis should follow a stepwise approach starting with conservative measures such as rest, ice, NSAIDs, and activity modification, with progression to more invasive treatments only if symptoms persist. 1

Initial Assessment and Conservative Management

  • Bursitis treatment should be tailored to the specific location (axial, peripheral, entheseal) and current symptoms, considering disease activity, pain level, and functional limitations 2
  • First-line treatment includes:
    • Rest and activity modification to reduce pressure on the affected area 1
    • Ice application for 10-minute periods through a wet towel for pain relief 1
    • NSAIDs for pain and inflammation control 1, 3
  • For acute bursitis, naproxen is specifically indicated at a recommended starting dose of 500 mg, followed by 500 mg every 12 hours or 250 mg every 6-8 hours as required 3
  • The initial total daily dose of naproxen should not exceed 1250 mg, with subsequent daily doses not exceeding 1000 mg 3
  • Use the lowest effective NSAID dose for the shortest duration consistent with treatment goals to minimize side effects 3

Intermediate Interventions

  • If NSAIDs are insufficient, contraindicated, or poorly tolerated, analgesics such as paracetamol and opioids might be considered for pain control 2
  • Corticosteroid injections directed to the local site of musculoskeletal inflammation may be considered for certain types of bursitis, such as prepatellar and olecranon bursitis 1, 4
  • Caution: Steroid injections should be avoided in retrocalcaneal bursitis as they may adversely affect the biomechanical properties of the Achilles tendon 1, 4
  • For trochanteric bursitis, ultrasound-guided bursal injection with lidocaine (as a diagnostic test) or in combination with a corticosteroid may be beneficial 2

Management of Specific Types of Bursitis

  • Prepatellar and olecranon bursitis:

    • Conservative management with ice, NSAIDs, and activity modification 4, 5
    • Bursal aspiration may shorten symptom duration in acute traumatic/hemorrhagic bursitis 5
    • Avoid aspiration in chronic microtraumatic bursitis due to risk of iatrogenic infection 5
    • Intrabursal corticosteroid injections may be used, though high-quality evidence for benefit is limited 5, 6
  • Trochanteric bursitis:

    • Conservative management as first-line treatment 4, 7
    • Surgical intervention may be required for recalcitrant cases 4
  • Septic bursitis:

    • Requires bursal aspiration with fluid examination (Gram stain, culture) 5
    • Antibiotics effective against Staphylococcus aureus are generally the initial treatment 5, 8
    • Outpatient antibiotics for non-acutely ill patients; hospitalization with IV antibiotics for acutely ill patients 5
    • Recovery from septic bursitis can take months 8

Advanced Interventions

  • Immobilization with a cast or fixed-ankle walker-type device may be necessary for heel bursitis 1
  • Referral to specialists (rheumatologist, orthopedic surgeon, podiatric foot and ankle surgeon) should be considered for:
    • Recalcitrant cases not responding to conservative treatment 1
    • Suspected systemic rheumatic disease (presence of multiple symptomatic bursae) 1
  • Surgical intervention may be required for refractory bursitis, such as:
    • Resection of the prominent posterior superior aspect of the calcaneus and inflamed bursa for heel bursitis 1
    • Bursectomy for chronic olecranon bursitis unresponsive to conservative measures 6

Prevention and Monitoring

  • Disease monitoring should include patient history, clinical parameters, and appropriate testing according to clinical presentation 2
  • Complete immobilization should be avoided to prevent muscular atrophy and deconditioning 1
  • Address underlying causes of chronic microtraumatic bursitis to prevent recurrence 5
  • The frequency of monitoring should be individualized based on symptoms, severity, and treatment response 2

References

Guideline

Management of Bursitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Four common types of bursitis: diagnosis and management.

The Journal of the American Academy of Orthopaedic Surgeons, 2011

Research

Common Superficial Bursitis.

American family physician, 2017

Research

Clinical Management of Olecranon Bursitis: A Review.

The Journal of hand surgery, 2021

Research

Lower extremity bursitis.

American family physician, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.